Literature DB >> 9557233

The pilosebaceous unit is part of the skin immune system.

M Böhm1, T A Luger.   

Abstract

It is well established that the functional state of sebaceous glands in vivo is a tightly regulated process orchestrated through the interaction of male sex hormones and functional androgen receptors expressed on sebocytes. In the last few years, however, it has become increasingly apparent that sebocytes like epidermal keratinocytes express a variety of cytokines which are implicated in inflammatory and immune responses. For example, sebocytes in vivo have been found to highly express tumor necrosis factor alpha (TNF-alpha) as determined by immunohistochemical and electron-microscopic methods. Moreover, certain neuropeptides including vascular intestinal peptide and proopiomelanocortin (POMC) peptides as well as their receptors have been localized within the pilosebaceous unit of murine and human skin. Since POMC peptides such as alpha-melanocyte-stimulating hormone have recently been shown to exert important immunoregulatory effects by antagonizing the function of proinflammatory cytokines (e.g interleukin 1, interleukin 6 and TNF-alpha), induction of immunosuppressive cytokines (like interleukin 10), modulation of costimulatory molecule expression (e.g. B7-2) or suppression of macrophage-derived nitric oxide, complex interactions between these mediators and their target cells within the pilosebaceous gland seem to exist. The successful cultivation of sebocytes will provide a model by which the effect of these mediators can be studied in detail in order to shed light onto the various pathophysiological conditions of sebaceous glands.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557233     DOI: 10.1159/000017874

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  4 in total

Review 1.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 2.  [Alpha-melanocyte-stimulating hormone. Its current significance for dermatology].

Authors:  M Böhm; T A Luger
Journal:  Hautarzt       Date:  2004-05       Impact factor: 0.751

Review 3.  Current concepts of the pathogenesis of acne: implications for drug treatment.

Authors:  Harald Gollnick
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Proteomic analysis of human meibomian gland secretions.

Authors:  P S Tsai; J E Evans; K M Green; R M Sullivan; D A Schaumberg; S M Richards; M R Dana; D A Sullivan
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.